A biosensor mainly consists of three parts, including a component that detects the analyte and generates a signal, a signal transducer, and a reader device. Biosensors find their applications in food and beverages, environmental monitoring, home care diagnostics. and various nanomechanical biosensors. In addition, biosensor applications to study metabolic processes are also widely prevalent in the field of plant biology.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/1476
Significant increase in chronic diseases such as diabetes across the globe, increase in biotechnology research and development, and growing demand for home care devices are the major factors fueling the growth of the biosensor market. Additionally, significant rise in preference of biosensors in glucose monitoring devices is contributing to the growth of the market. High costs associated with these devices and inclination to adopt new treatment devices are the major factors hindering the growth of the market. Conversely, technological advances in biosensors making them portable and easy to handle are expected to create lucrative opportunities in the future.
The market is segmented on the basis of product, technology and
region. On the basis of product, the global biosensor market is segmented into
wearable biosensors and non-wearable biosensors. On the basis of technology,
the market is classified into electrochemical biosensors, optical biosensors,
piezoelectric biosensors, thermal biosensors, and nanomechanical biosensors. By
region, it is analyzed in North America, Europe, Asia-Pacific and LAMEA.
Major factors driving the growth of the biosensor market in
Asia-Pacific include rise in per capita income in several countries, rise in
government initiatives to improve the healthcare sector, and increase in focus
of leading manufacturers on expanding their geographical presence among
emerging manufacturers. Asia-Pacific countries will exploit the high growth
opportunities in the market.
Allied Market Research published a report, Biosensors Market was valued at $17,500.0 million in 2018 and is expected to reach $38,600.2 million by 2026, registering a CAGR of 10.4% from 2019 to 2026. Biosensors are medical devices primarily used to detect or detect the presence or concentration of biological substances or microorganisms such as biological substances. They are analytical devices that can convert a biological response into an electrical signal.
Leading Market Players:
Comprehensive competitive analysis
and profiles of major market players such as Some of the key players of the
market include
·
Abbott
Laboratories,
·
AgaMatrix
Holdings LLC,
·
DowDupont Inc.
(DuPont de Nemours, Inc.),
·
F. Hoffmann-La
Roche Ltd.,
·
General
Electric (Biacore, Inc.),
·
LifeScan, Inc.,
·
Medtronic Plc.,
·
Nova
Biomedical,
·
PHC Holdings
Co., Ltd. (Ascensia Diabetes Care Holdings AG)
·
Siemens
Healthcare
0 Comments